Adverum Biotechnologies (ADVM) Prices 14.5M Share Common Offering at $13/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Pre-Open Stock Stock Movers 08/12: (PEIX) (MRNA) (TSLA) Higher; (TRVN) (SMCI) (PLUG) Lower (more...)
August 12, 2020 9:25 AM EDTPre-Open Stock Movers:
Pacific Ethanol (NASDAQ: PEIX) 21% HIGHER; reported Q2 EPS of $0.27, versus ($0.17) reported last year. Revenue for the quarter came in at $212.1 million, versus $346.3 million reported last year. Looking at the second half of the year, we expect Adjusted EBITDA to range between $50 and $70 million, with momentum continuing into 2021."
Trevena, Inc. (Nasdaq: TRVN) 16.4% LOWER; intends to offer and sell shares of its common stock in an underwritten public... More
After-Hours Stock Movers 08/11: (MRNA) (TSLA) (AOSL) Higher; (TRVN) (RRGB) (PLUG) Lower (more...)
August 11, 2020 6:12 PM EDTAfter-Hours Stock Movers:
Pacific Ethanol (NASDAQ: PEIX) 21% HIGHER; reported Q2 EPS of $0.27, versus ($0.17) reported last year. Revenue for the quarter came in at $212.1 million, versus $346.3 million reported last year. Looking at the second half of the year, we expect Adjusted EBITDA to range between $50 and $70 million, with momentum continuing into 2021."
Trevena, Inc. (Nasdaq: TRVN) 16.4% LOWER; intends to offer and sell shares of its common stock in an underwritten public offering. In addition,... More
Adverum Biotechnologies (ADVM) Announces $200M Common Share Offering
August 11, 2020 4:02 PM EDTAdverum Biotechnologies, Inc. (NASDAQ: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that it has commenced an underwritten public offering of $200 million of its common stock. The company intends to grant the... More

